Statins give bone growth a boost

Abstract

Although our understanding of the cellular processes that go awry in dwarfism is good, development of treatments has been hampered by a lack of efficient methods for screening and testing potential drugs. In this issue, Yamashita et al.1 (page 507) report a major step forward in solving this problem, establishing a human-disease-based system for screening potential drugs to treat skeletal-growth defects.